BEIJING U.S. pharmaceutical giant Eli Lilly has reached a $2.75 billion deal to bring drugs developed using artificial intelligence by Hong Kong-based Insilico Medicine to the global market. The agr… [+1824 chars]
Read More
The spring migration is upon us, so why not make the most of it? The spring migration is upon us,...
On Tuesday, OpenAI announced that the company is shutting down Sora, its AI-generated video app. ...
Berkshire Hathawayscash-rich balance sheet and other defensive attributes hasnt helped much in th...
Attorney Mark Lanier moonlights as a preacher, and it shows when he is taking on the worlds most ...
If the strait stays closed, the world will have to significantly reduce its oil and gas consumpti...
Then $75 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.
Analysis by Antoine Gara, Sujeet Indap
Read AnalysisFour weeks into the Iran conflict, global financial markets are starting to show some serious signs of strain. Worries about the inflationary impact of rising crude-oil prices, coupled with a serie...
Analysis by Joseph Adinolfi
Read Analysis
For investors and traders navigating the current volatility, here is a backdrop of what happened over the recent trading sessions, characterized by escalating geopolitical tension and significant m...
Analysis by Itai Levitan
Read Analysis
Key takeaways: The Federal Communications Commission has banned the sale of new foreign-made routers in the US. The sweeping order applies to virtually every Wi-Fi router currently available… [+930...
Analysis by See full bio
Read Analysis
One thought kept going through Tijuanna Fishers mind as she lay on the elevator floor in her Northwest Washington apartment building for what seemed like forever last fall: Please, God, dont let me...
Analysis by Joe Heim
Read Analysis